Christiano Anthony V, Pean Christian A, Kugelman David N, Konda Sanjit R, Egol Kenneth A
Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
Department of Orthopaedic Surgery, NYULMC Hospital for Joint Diseases, New York, New York.
J Knee Surg. 2020 May;33(5):481-485. doi: 10.1055/s-0039-1678676. Epub 2019 Feb 27.
The purpose of this study is to determine when functional outcome no longer improves following tibial plateau fracture. A patient series of operatively treated tibial plateau fractures was reviewed. Patients were evaluated using the short musculoskeletal function assessment (SMFA), range of motion (ROM) assessment, and pain levels at visual analog scale (VAS) at 3, 6, and 12 months postoperatively. Fractures were classified by the Schatzker's classification using preoperative imaging. The case series was divided into two groups based on fracture patterns. Friedman's tests were conducted to determine if there were differences in SMFA, ROM, or VAS throughout the postoperative course. A total of 117 patients with tibial plateau fractures treated operatively, with complete follow-up and without complication, were identified. Seventy-seven patients (65.8%) sustained lateral tibial plateau fractures (Schatzker's I-III). Friedman's test demonstrated significant differences in SMFA ( < 0.0005) and ROM ( < 0.0005) at the three time points. Post hoc analysis demonstrated a significant difference in SMFA ( < 0.0005) and ROM ( = 0.003) between 3 and 6 months postoperatively but no significant difference in either metric between 6 and 12 months postoperatively. Friedman's test demonstrated no significant difference in VAS postoperatively ( = 0.210). Forty patients (34.2%) sustained medial or bicondylar tibial plateau fractures (Schatzker's IV-VI). Friedman's test demonstrated significant differences in SMFA ( < 0.0005) and ROM ( < 0.0005) at the three time points. Post hoc analysis demonstrated a strong trend toward significance in SMFA between 3 and 6 months postoperatively ( = 0.088), and demonstrated a significant difference between 6 and 12 months postoperatively ( = 0.013). ROM was found to be significantly different between 3 and 6 months postoperatively ( = 0.010), but no difference was found between 6 and 12 months postoperatively ( = 0.929). Friedman's test demonstrated no significant difference in VAS postoperatively ( = 0.941). In this cohort, no significant difference in function, ROM, or pain level exists between 6 and 12 months after treatment of lateral tibial plateau fractures. However, there are significant improvements in function for at least 1 year following medial or bicondylar tibial plateau fractures.
本研究的目的是确定胫骨平台骨折后功能结果何时不再改善。回顾了一组接受手术治疗的胫骨平台骨折患者。在术后3个月、6个月和12个月,使用简短肌肉骨骼功能评估(SMFA)、活动范围(ROM)评估以及视觉模拟量表(VAS)评估疼痛水平对患者进行评估。术前通过影像学检查按照Schatzker分类法对骨折进行分类。根据骨折类型将病例系列分为两组。进行Friedman检验以确定术后整个过程中SMFA、ROM或VAS是否存在差异。共确定了117例接受手术治疗、随访完整且无并发症的胫骨平台骨折患者。77例患者(65.8%)发生外侧胫骨平台骨折(Schatzker I - III型)。Friedman检验显示在三个时间点SMFA(<0.0005)和ROM(<0.0005)存在显著差异。事后分析显示术后3个月和6个月之间SMFA(<0.0005)和ROM(=0.003)存在显著差异,但术后6个月和12个月之间这两个指标均无显著差异。Friedman检验显示术后VAS无显著差异(=0.210)。40例患者(34.2%)发生内侧或双髁胫骨平台骨折(Schatzker IV - VI型)。Friedman检验显示在三个时间点SMFA(<0.0005)和ROM(<0.0005)存在显著差异。事后分析显示术后3个月和6个月之间SMFA有显著意义的强烈趋势(=0.088),且术后6个月和12个月之间存在显著差异(=0.013)。发现术后3个月和6个月之间ROM存在显著差异(=0.010),但术后6个月和12个月之间无差异(=0.929)。Friedman检验显示术后VAS无显著差异(=0.941)。在该队列中,外侧胫骨平台骨折治疗后6个月和12个月之间功能、ROM或疼痛水平无显著差异。然而,内侧或双髁胫骨平台骨折后至少1年内功能有显著改善。